MISTI MARSH: Open Payments
NPI 1467172387 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 67 payments from 20 companies in 2025. Trend: 2023 $803 · 2024 $857 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $268 |
| Axsome Therapeutics, Inc. | 12 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $139 |
| Novo Nordisk Inc | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Exact Sciences Corporation | 3 | $46 |
| Verona Pharma, Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
Products named: Auvelity, UBRELVY, QULIPTA, AIRSUPRA, VRAYLAR, GLASSIA, VOQUEZNA, Kerendia.
Industry payments across IN — which companies pay providers there.
